VB

Vipul Babu Cherusseriparambil Sivasankaran

Active Director Designated Partner DIN 11451504
DIN 11451504 First appointment Dec 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Vipul Babu Cherusseriparambil Sivasankaran

Data last updated:

Vipul Babu Cherusseriparambil Sivasankaran is a Designated Partner at Mycochondria Llp (since 2025).

DIN 11451504
Primary Designation Designated Partner
First Appointment 26 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mycochondria Llp ACT-8029
Designated Partner26 Dec 20252025Active

Board colleagues of Vipul Babu Cherusseriparambil Sivasankaran

NameDINCompanyDesignation
Basil Mathai Komayil Mathai11451503Mycochondria LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Mycochondria Llp
Premium access

Shareholding and investment profile for Vipul Babu Cherusseriparambil Sivasankaran

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vipul Babu Cherusseriparambil Sivasankaran

Vipul Babu Cherusseriparambil Sivasankaran currently holds 1 directorship: Mycochondria Llp (Designated Partner, since 26 Dec 2025).

Vipul Babu Cherusseriparambil Sivasankaran was first appointed on 26 Dec 2025 as Designated Partner at Mycochondria Llp.

The current boards of Vipul Babu Cherusseriparambil Sivasankaran's companies include Basil Mathai Komayil Mathai (Mycochondria Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available